Abstract
The epidemic caused by the human immunodeficiency virus (HIV-1) is the most important emerging infection in the last decades. Despite that, there is no effective vaccine against this virus yet. It is expected that prevention should be achieved by the action of neutralizing antibodies, mainly directed against the virus envelope glycoprotein (gp140), while reduction of virus replication and…